Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Applications Based on Data from Public Domain Recommended for 8 Drugs
July 11, 2011
- NST Reduces Hospitalization Cost by ¥0.4 Mil per Patient: NCGM
July 11, 2011
- KHK Preparing for Expected Leap in Growth from 2014-2015: President Matsuda
July 11, 2011
- Korosho Abolishes Confirmation Application System for Regenerative Medicines
July 11, 2011
- MRs should Help Improve Quality of Healthcare as Medical Team Members: Prof. Muto
July 11, 2011
- Astellas Sells DPP-4 Inhibitor-related Patent Estate to Royalty Pharma for US$609 Mil.
July 11, 2011
- FDA Accepts Pfizer's Application for Axitinib for RCC
July 11, 2011
- Celecoxib Significantly Lowers Incidence of Ulcers vs Loxoprofen
July 11, 2011
- CMIC to Acquire Investigational Drug Manufacturing Facilities from Daiichi Sankyo
July 11, 2011
- Regenerative Medicine Industry Organization Kicks Off
July 11, 2011
- JES Calls for Approval of Monotherapy with Novel Antiepileptic Agents
July 11, 2011
- Sogo Medical to Increase Number of Mentaio Pharmacies to 20 in 3 Years
July 11, 2011
- DPJ Lawmakers Call for Withdrawal of Proposal to Unify Basic Dispensing Fees
July 11, 2011
- DPJ's Diet Members Adopt Opinion Paper Calling for Deregulating Online Sales of OTC Drugs
July 11, 2011
- Mediceo to Use Its MR-Certified MSs to Promote Orphan Drugs
July 11, 2011
- Ono, Evotec Succeed in Discovering Lead Compounds in Iron Channel Drug Discovery
July 11, 2011
- Eisai to Enhance Liver Disease Franchise in Asia/Pacific Region
July 11, 2011
- Pfizer Remains Top Global Drug Maker; Mergers Shake up Ranking
July 11, 2011
- Sanofi-aventis, Tohoku Univ. Sign Comprehensive Agreement for Life Science Research
July 11, 2011
- 24 APIs/34 Products Approved Following New Procedures
July 11, 2011
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…